Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

GlucoTrack, Inc. - Common Stock (NQ: GCTK )

0.3650 +0.0160 (+4.58%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 272,976
Open 0.3385
Bid (Size) 0.3470 (20)
Ask (Size) 0.3649 (1)
Prev. Close 0.3490
Today's Range 0.3347 - 0.3750
52wk Range 0.3067 - 99.00
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Glucotrack Appoints Guillermo Umpierrez, MD, CDCES, FACE, MACP as New Medical Advisory Board Member
Leading diabetes researcher and clinician joins Glucotrack as Company advances development of long-term implantable blood glucose monitoring technology 
From Glucotrack, Inc.
Via GlobeNewswire
Glucotrack Commences Transition From Concept To Reality With Breakthrough Clinical Trial
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire

Performance

YTD
-94.26%
-94.26%
1 Month
-31.67%
-31.67%
3 Month
-93.46%
-93.46%
6 Month
-99.38%
-99.38%
1 Year
-98.86%
-98.86%

More News

Read More
Glucotrack Commences Transition From Concept To Reality With Breakthrough Clinical Trial
Via TheNewswire.com
What's going on in today's session
Via Chartmill
How Is The Market Feeling About GlucoTrack?
Via Benzinga
Top movers analysis one hour before the close of the markets on 2025-02-04: top gainers and losers in today's session.
Via Chartmill
Tuesday's session: top gainers and losers
Via Chartmill
Traders are paying attention to the gapping stocks in Tuesday's session.
Via Chartmill
Glucotrack Announces Successful Completion of Its First Human Clinical Study of Continuous Blood Glucose Monitor
From Glucotrack, Inc.
Via GlobeNewswire
Which stocks are most active on Thursday?
Via Chartmill
There are notable gap-ups and gap-downs in today's session.
Via Chartmill
Stay updated with the stocks that are on the move in today's pre-market session.
Via Chartmill
Glucotrack Announces Reverse Stock Split
From Glucotrack, Inc.
Via GlobeNewswire
Glucotrack Strengthens Leadership Team with Appointment of New Chief Financial Officer
From Glucotrack, Inc.
Via GlobeNewswire
Glucotrack Announces ISO 13485:2016 Certification
From Glucotrack, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Why Taiwan Semiconductor Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Glucotrack Strenghtens Leadership Team with Addition of Industry Veteran as Vice President of Regulatory Affairs
From Glucotrack, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Why Vision Marine Technologies Shares Are Trading Higher By 68%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Why Sage Therapeutics Shares Are Trading Higher By Over 34%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Glucotrack to Present at TechBio Showcase™ 2025
From Glucotrack, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Driving Innovation In Diabetes Management: Glucotrack Begins Enrollment For Human Clinical Trials For Its Implantable Continuous Blood Glucose Monitor
Via News Direct
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.